Showing results (1-10 of 625) with videos related to
Sort By:
Pageof 63
Deutsche Medizinische Wochenschrift (1946)|February 5, 2020
[Current diagnostic and therapeutic standards in aggressive B-cell lymphomas]Birte Friedrichs, Norbert Schmitz, Georg LenzCurrent Opinion in Oncology|August 11, 2018
The role of allogeneic stem cell transplantation in T-cell lymphomaBirte Friedrichs, Matthias Stelljes, Norbert SchmitzExpert Review of Hematology|October 5, 2019
Therapeutic potential of PI3K signaling in distinct entities of B-cell lymphomaRamona Wullenkord, Birte Friedrichs, Tabea Erdmann, et al.Blood|April 28, 2018
Allogeneic hematopoietic stem cell transplantation for T-cell lymphomasNorbert Schmitz, Georg Lenz, Matthias StelljesLeukemia & Lymphoma|July 15, 2006
Survivin-derived peptide epitopes and their role for induction of antitumor immunity in hematological malignanciesBirte Friedrichs, Sandra Siegel, Mads Hald Andersen, et al.Therapeutic Advances in Hematology|July 5, 2022
Current options and future perspectives in the treatment of patients with relapsed/refractory diffuse large B-cell lymphomaFabian Frontzek, Imke Karsten, Norbert Schmitz, et al.British Journal of Haematology|October 28, 2024
Sequencing of therapy for patients with diffuse large B-cell lymphoma in the era of novel drugsImke E Karsten, Evgenii Shumilov, Norbert Schmitz, et al.Haematologica|September 12, 2006
The effects of rituximab treatment during pregnancy on a neonateBirte Friedrichs, Markus Tiemann, Hans Salwender, et al.British Journal of Haematology|December 7, 2018
Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trialBirte Friedrichs, Maike Nickelsen, Marita Ziepert, et al.Biomedicines|June 2, 2021
Radiotherapy in Follicular Lymphoma Staged by 18F-FDG-PET/CT: A German Monocenter StudyImke E Karsten, Gabriele Reinartz, Michaela Pixberg, et al.Pageof 63